Avaleht › Skisofreenia › Georgia
Skisofreenia kliinilised uuringud osariigis Georgia
29 uuringut haiguse Skisofreenia jaoks otsivad osalejaid osariigis Georgia.
Linnad osariigis Georgia
Ametlik uuringutekst (inglise keeles)
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Decatur
VärbamineFaas 4
Vanused 12–17 · Kõik sood · Uuendatud 1. okt 2026 · NCT05648591A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Synexus Clinical Research US Inc, Atlanta
VärbamineFaas 1
Vanused 18–55 · Kõik sood · Uuendatud 28. sept 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Local Institution - 0070, Sandy Springs
- Local Institution - 0189, Savannah
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 28. sept 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
VärbamineFaas 3
Vanused 5–17 · Kõik sood · Uuendatud 25. sept 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- ja veel 1
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
VärbamineFaas 3
Vanused 5–17 · Kõik sood · Uuendatud 22. sept 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Augusta University, Augusta
VärbamineFaas 2
Vanused 18–55 · Kõik sood · Uuendatud 22. sept 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. sept 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CenExel iResearch, LLC, Decatur
VärbamineFaas 1
Vanused 18–55 · Kõik sood · Uuendatud 17. sept 2026 · NCT0773449352-week Open Label Safety-Tolerability Study
- CenExel, Atlanta
- Accelerated Clinical Trial, Snellville
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 9. sept 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
VärbamineFaas 3
Vanused 13–17 · Kõik sood · Uuendatud 4. sept 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, LLC, Decatur
VärbamineFaas 1
Vanused 18–55 · Kõik sood · Uuendatud 2. sept 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Atlanta
- Clinical Site, Decatur
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 1. sept 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Emory University., Atlanta
- Local Institution - 0049, Austell
- Local Institution - 0044, Marietta
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 19. aug 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Decatur
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 14. aug 2026 · NCT05303064Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
VärbamineFaas 1
Vanused 10–17 · Kõik sood · Uuendatud 11. aug 2026 · NCT05025605Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CenExel iResearch, Decatur
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 29. juuli 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Accelerated Clinical Trial, Snellville
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 27. juuli 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel ACMR, Atlanta
- Cenexel iResearch Atlanta, Decatur
VärbamineFaas 2
Vanused 18–55 · Kõik sood · Uuendatud 23. juuni 2026 · NCT07191483Anti-Inflammatory Challenge in Schizophrenia
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
VärbamineFaas 4
Vanused 18–55 · Kõik sood · Uuendatud 3. juuni 2026 · NCT05823532CLOZAPINE Response in Biotype-1
- University of Georgia, Athens
VärbamineFaas 4
Vanused 18–60 · Kõik sood · Uuendatud 11. mai 2026 · NCT04580134Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- Augusta University Research Institute, Inc., Augusta
VärbamineFaas 4
Vanused 18–65 · Kõik sood · Uuendatud 4. mai 2026 · NCT05208190Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
VärbamineVaatlusuuring
Vanused 18–40 · Kõik sood · Uuendatud 10. märts 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- Neurocrine Clinical Site, Snellville
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 6. märts 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Peachtree Corners
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 12. jaan 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5064, Snellville
VärbamineFaas 2
Vanused 21–55 · Kõik sood · Uuendatud 26. dets 2025 · NCT06502964Cognitive Training for Emotion Regulation in Psychotic Disorders
- University of Georgia, Athens
Värbamine
Vanused 18–60 · Kõik sood · Uuendatud 5. veebr 2025 · NCT04414215Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Atlanta
- Reviva site, Decatur
VärbamineFaas 3Terved vabatahtlikud oodatud
Vanused 18–65 · Kõik sood · Uuendatud 19. dets 2024 · NCT05184335Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.